Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

45 filings reported holding INZY - Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30,838,062 shares of 64,967,756 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include Sofinnova Investments, Inc. (3,655,308 shares), Deep Track Capital, LP (3,250,000 shares), Rock Springs Capital Management LP (2,807,618 shares), VR Adviser, LLC (2,709,987 shares), Pivotal bioVenture Partners Investment Advisor LLC (2,661,154 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,596,672 shares), NEA Management Company, LLC (2,444,379 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,090,436 shares), CHI Advisors LLC (1,996,277 shares), and VANGUARD GROUP INC (1,343,063 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.